Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Alonso García Ruiz

Vall d´Hebron Institut d´Oncologia

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

100%

Radiology

80%

In Vivo Imaging

50%

Brain Tumor

50%

Diffusion Mri

50%

Tissue Imaging

50%

Tumor Heterogeneity

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Reply to Anwar R. Padhani, Frederic LeCouvet, Giuseppe Petralia, and Dow-Mu Koh’s Letter to the Editor re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016

Article Link

Year:

2024

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion‐Relaxation MRI

Article Link

Year:

2024

Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer

Article Link

Year:

2024

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

Article Link

Year:

2024

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial

Article Link

Year:

2024

Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles

Article Link

Year:

2024

Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial

Article Link

Year:

2023

MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors

Article Link

Year:

2023

Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics

Article Link

Year:

2022

Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis

Article Link

Year:

2022

Diffuse Large B-Cell Epstein-Barr Virus–Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics

Article Link

Year:

2022

Robust imaging habitat computation using voxel-wise radiomics features

Article Link

Year:

2021

A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Article Link

Year:

2021

Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer

Article Link

Year:

2020

Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI

Article Link

Year:

2020

Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis

Article Link

Year:

2020

Collaborators7

Jordi Bruna

Coordinator in Chief of the Neuro-Oncology Unit

SPAIN

Joan Seoane

Hospital Universitari Vall d'Hebron

SPAIN

Ignacio Matos

Clinica Universidad de Navarra

SPAIN

Annette Byrne

Associate Professor and Principal Investigator

Royal College of Surgeons in Ireland

IRELAND

Nuria Roson Gradaille

Chief abdominal radiology unit

Hospital Universitari Vall d'Hebron

SPAIN

Roser Sala-Llonch

Associate Professor

University of Barcelona

SPAIN

Francesco Sanguedolce

Institut de Recerca Sant Pau

SPAIN

How do I reach out?

Meet Kite AI